Business
A Vaccine Against a Widespread Common Cold Type Just Passed Promising Clinical Trials – ScienceAlert
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
A vaccine designed to prevent one of the most widespread common cold types has just delivered promising results in the latest set of clinical trials, and the developers now think it could actually reach the market in just a few years.
The cold, known as respiratory syncytial virus (RSV), is so common, more than 90 percent of kids contract it by the age of two. In fact, this dangerous and sometimes deadly infection is the leading cause of serious lower respiratory diseases in children worldwide…
-
Noosa News15 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General13 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News14 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Business16 hours agoSolid superannuation gains continue to roll in